Saipem Secures €700 Million Contract For New Biorefinery
Valued at approximately €700 million upon completion, the contract covers engineering, procurement, and construction (EPC) activities, with works scheduled to be completed by the end of 2028.
The scope of the agreement includes detailed engineering design, procurement of materials, and construction of the main processing units of the facility.
The project strengthens ongoing cooperation between Eni and Saipem in the field of biorefining in Italy, building on agreements signed in 2023 and later extended in 2025.
The new Priolo biorefinery will have an annual processing capacity of 500,000 tonnes and is designed to offer operational flexibility for the production of sustainable aviation fuel (SAF) biojet fuel and hydrotreated vegetable oil (HVO) diesel.
Saipem said the contract further reinforces its position in the construction of biorefineries, highlighting its engineering and technological capabilities developed through industrial conversion and transformation projects supporting the energy transition.
Saipem is a global engineering and construction company active in energy and infrastructure projects across offshore and onshore segments. The company operates through business lines including Asset Based Services, Drilling, Energy Carriers, Offshore Wind, and Sustainable Infrastructures.
It employs around 30,000 people of more than 130 nationalities and is present in over 50 countries. Listed on the Milan Stock Exchange, Saipem positions itself under the motto“Engineering for a sustainable future,” with a focus on supporting clients in the energy transition toward net zero through digital and sustainable technologies.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment